Dyskinesia, Drug-Induced < Dyskinesias < Dyslipidemias

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 32.
[0-20] [0 - 20][0 - 32][20-31][20-40]

Ident.	Authors (with country if any)	Title
000063 (1999)	P. Pollak [France]	Neurosurgical treatment of dyskinesias: pathophysiological consideration.
000149 (2000)	J. Yelnik [France] ; P. Damier ; B P Bejjani ; C. Francois ; D. Gervais ; D. Dormont ; I. Arnulf ; A. M Bonnet ; P. Cornu ; B. Pidoux ; Yves Agid [France]	Functional mapping of the human globus pallidus: contrasting effect of stimulation in the internal and external pallidum in Parkinson's disease.
000219 (2001)	P. Krystkowiak [France] ; J L Blatt ; J L Bourriez ; A. Duhamel ; M. Perina ; G. Kemoun ; S. Blond ; J D Guieu ; A. Destée ; L. Defebvre	Chronic bilateral pallidal stimulation and levodopa do not improve gait in the same way in Parkinson's disease: a study using a video motion analysis system.
000332 (2003)	Jean-Luc Houeto [France] ; Marie-Laure Welter ; Paul-Boulos Bejjani ; Sophie Tezenas Du Montcel ; Anne-Marie Bonnet ; Valerie Mesnage ; Soledad Navarro ; Bernard Pidoux ; Didier Dormont ; Philippe Cornu ; Yves Agid [France]	Subthalamic stimulation in Parkinson disease: intraoperative predictive factors.
000386 (2003)	Michel Bonduelle ; Jean Cambier	[The Luys' body].
000396 (2003)	E. Labyt [France] ; D. Devos ; J-L Bourriez ; F. Cassim ; A. Destée ; J-D Guieu ; L. Defebvre ; P. Derambure	Motor preparation is more impaired in Parkinson's disease when sensorimotor integration is involved.
000436 (2004)	Vincent Paillé [France] ; Philippe Brachet ; Philippe Damier	Role of nigral lesion in the genesis of dyskinesias in a rat model of Parkinson's disease.
000444 (2004)		Extrapyramidal reactions to SSRI antidepressant + neuroleptic combinations.
000517 (2005)		Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
000520 (2005)	Stéphane Thobois [France] ; Florence Delamarre-Damier ; Pascal Derkinderen	Treatment of motor dysfunction in Parkinson's disease: an overview.
000569 (2005)	M. Péchevis [France] ; C E Clarke ; P. Vieregge ; B. Khoshnood ; C. Deschaseaux-Voinet ; G. Berdeaux ; M. Ziegler	Effects of dyskinesias in Parkinson's disease on quality of life and health-related costs: a prospective European study.
000640 (2006)	D. Guehl [France] ; E. Cuny ; A. Benazzouz ; A. Rougier ; F. Tison ; S. Machado ; D. Grabot ; C. Gross ; B. Bioulac ; P. Burbaud	Side-effects of subthalamic stimulation in Parkinson's disease: clinical evolution and predictive factors.
000669 (????)	Robert A. Hauser [États-Unis] ; Hermann Russ ; Doris-Anita Haeger ; Michel Bruguiere-Fontenille ; Thomas Müller ; Gregor K. Wenning	Patient evaluation of a home diary to assess duration and severity of dyskinesia in Parkinson disease.
000679 (2007)	B. Ballanger [France] ; R. Gil ; M. Audiffren ; M. Desmurget	Perceptual factors contribute to akinesia in Parkinson's disease.
000686 (2007)	Vincent Paillé [France] ; Vincent Henry ; Laurent Lescaudron ; Philippe Brachet ; Philippe Damier	Rat model of Parkinson's disease with bilateral motor abnormalities, reversible with levodopa, and dyskinesias.
000701 (2007)	Abid Oueslati [France] ; Véronique Sgambato-Faure ; Christophe Melon ; Philippe Kachidian ; Paolo Gubellini ; Mohammed Amri ; Lydia Kerkerian-Le Goff ; Pascal Salin	High-frequency stimulation of the subthalamic nucleus potentiates L-DOPA-induced neurochemical changes in the striatum in a rat model of Parkinson's disease.
000841 (2008)	Erwan Bezard [France]	[Striatal proteomic analysis suggests that first L-dopa dose equates to chronic exposure].
000924 (2008)	S. Lesage [France] ; S. Belarbi ; A. Troiano ; C. Condroyer ; N. Hecham ; P. Pollak ; E. Lohman ; T. Benhassine ; F. Ysmail-Dahlouk ; A. Dürr ; M. Tazir ; A. Brice	Is the common LRRK2 G2019S mutation related to dyskinesias in North African Parkinson disease?
000948 (????)	A. Annic [France] ; D. Devos ; D. Seguy ; K. Dujardin ; A. Destée ; L. Defebvre	[Continuous dopaminergic stimulation by Duodopa in advanced Parkinson's disease: Efficacy and safety].
000949 (2009)	Sébastien Montel [France] ; Anne-Marie Bonnet ; Catherine Bungener	Quality of life in relation to mood, coping strategies, and dyskinesia in Parkinson's disease.
000955 (2009)	David Maltête [France] ; Nathalie Chastan ; Stéphane Derrey ; Bertrand Debono ; Emmanuel Gérardin ; Romain Lefaucheur ; Bruno Mihout ; Didier Hannequin	Microsubthalamotomy effect at day 3: screening for determinants.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i -k "Dyskinesias" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i  \
                -Sk "Dyskinesias" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Dyskinesias
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024